MULTIFOCAL MYOCLONUS AND SEIZURES IN EXTREMELY HIGH-DOSE OPIOID ADMINISTRATION

被引:0
|
作者
HAGEN, NA
SWANSON, R
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A400 / A400
页数:1
相关论文
共 50 条
  • [41] USE OF IMMUNOMODULATORY HIGH-DOSE SUBCUTANEOUS IMMUNOGLOBULIN IN TREATMENT OF OPSOCLONUS MYOCLONUS SYNDROME
    Alle, D.
    El-Dahr, J. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 371 - 371
  • [42] Moderate- vs high-dose methadone for opioid dependence
    Levinson, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (22): : 2122 - 2122
  • [43] Single high-dose buprenorphine for opioid craving during withdrawal
    Ahmadi, Jamshid
    Jahromi, Mina Sefidfard
    Ghahremani, Dara
    London, Edythe D.
    TRIALS, 2018, 19
  • [44] Perinatal Opioid Use Disorder Management with High-Dose Methadone
    Forero, Juan Pablo
    Vaughn, Rubi
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 : S193 - S194
  • [45] IS THERE A ROLE FOR HIGH-DOSE OPIOID ANESTHESIA IN THE 1990S
    HUG, CC
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1995, 42 (05): : R91 - R93
  • [46] Single high-dose buprenorphine for opioid craving during withdrawal
    Jamshid Ahmadi
    Mina Sefidfard Jahromi
    Dara Ghahremani
    Edythe D. London
    Trials, 19
  • [47] Considerations for implementing high-dose buprenorphine for opioid use disorder
    Mitragotri, Suhanee
    Zhu, David T.
    ADDICTION, 2025,
  • [48] PLASMA PROLACTIN CONCENTRATIONS DURING HIGH-DOSE OPIOID ANESTHESIA
    HYNYNEN, M
    LEHTINEN, AM
    SALMENPERA, M
    HEINONEN, J
    BRITISH JOURNAL OF ANAESTHESIA, 1988, 60 (02) : 245 - 246
  • [49] Pupillary Effects of High-dose Opioid Quantified with Infrared Pupillometry
    Rollins, Mark D.
    Feiner, John R.
    Lee, Jessica M.
    Shah, Sameer
    Larson, Merlin
    ANESTHESIOLOGY, 2014, 121 (05) : 1037 - 1044
  • [50] Effects of high-dose intravenous buprenorphine in experienced opioid abusers
    Umbricht, A
    Huestis, MA
    Cone, EJ
    Preston, KL
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (05) : 479 - 487